Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
· cnbc.com
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
A young female worker in protective gear carefully carries a container filled with blister-packaged capsules, a crucial step in the transportation process of ph...